Understanding barriers for adherence to follow-up care for abnormal pap tests?

Journal of Women's Health

Volumn 16, Issue 3, 2007, Pages 311-330

  Eggleston, Katherine S ^a   Coker, Ann L ^a   Das, Irene Prabhu ^b   Cordray, Suzanne T ^c   Luchok, Kathryn J ^d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Southen Institute of Children and Families   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER INVASION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCOME; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RACE; RACE DIFFERENCE; RISK FACTOR; SOCIOECONOMICS; SYSTEMATIC REVIEW; TELEPHONE; UNITED STATES; UTERINE CERVIX CANCER;

COUNSELING; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; UNITED STATES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 34247620485     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0161     Document Type: Article

References (44)

1. Schiffman MH, Brinton LA, Devesa SS, Fraumeni J, Joseph F. Cervical cancer. In: Schottenfeld D, Fraumeni J, Joseph F, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996.
2. Cancer facts and figures 2006. Atlanta: American Cancer Society, 2006.
3. Hughes E, McCracken M, Roberts H, et al. Surveillance for certain health behaviors among states and selected local areas - Behavioral Risk Factor Surveillance System, United States, 2004. MMWR Surveill Summ 2006;55:1.
4. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt JS. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 2003;60:294.
5. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. J Natl Cancer Inst 2005;97:675.
6. Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 2004;101:1188.
7. Abercrombie PD. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonat Nurs 2001;30:80.
8. Khanna N, Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: A review of barriers and interventions. J Am Board Fam Pract 2001;14:123.
9. McKee D Improving the follow-up of patients with abnormal Papanicolaou smear results. Arch Fam Med 1997;6:574.
10. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 2005;105:1323.
11. Cardin VA, Grimes RM, Jiang ZD, Pomeroy N, Harrell L, Cano P. Low-income minority women at risk for cervical cancer: A process to improve adherence to follow-up recommendations. Public Health Rep 2001;116:608.
12. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract 1993;37:583.
13. Crane LA. Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ 1996;11:164.
14. Eger RR, Peipert JF. Risk factors for noncompliance in a colposcopy clinic. J Reprod Med 1996;41:671.
15. Ell K, Vourlekis B, Muderspach L, et al. Abnormal cervical screen follow-up among low-income Latinas: Project safe. J Womens Health Gend Based Med 2002;11:639.
16. Engelstad LP, Stewart SL, Nguyen BH, et al. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev 2001;10:1015.
17. Engelstad LP, Stewart SL, Ostero-Sabogal R, Leung MS, Davis PI, Pasick RJ. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev Med 2005;41:741.
18. Fox P, Amsberger P, Zhang X. An examination of differential follow-up rates in cervical cancer screening. J Community Health 1997;22:199.
19. Hartz LE, Fenaughty AM. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet Gynecol 2001;98:674.
20. Jones BA, Novis DA. Follow-up of abnormal gynecologic cytology. Arch Pathol Lab Med 2000;124:665.
21. Kaplan CP, Bastani R, Belin TR, Marcus A, Nasseri K, Hu MY. Improving follow-up after an abnormal Pap smear: Results from a quasi-experimental intervention study. J Womens Health Gend Based Med 2000;9:779.
22. Lacey L, Whitfield J, DeWhite W, et al. Referral adherence in an inner city breast and cervical cancer screening program. Cancer 1993;72:950.
23. Lavin C, Goodman E, Perlman S, Kelly LS, Emans SJ. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic. J Pediatr Adolesc Gynecol 1997;10:141.
24. Lerman C, Hanjani P, Caputo C, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992;10:330.
25. Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: Results from a large clinic-based trial of three intervention strategies. Med Care 1992;30:216.
26. Marcus AC, Kaplan CP, Crane LA, et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 1998;36:397.
27. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med 1999;8:129.
28. McKee MD, Schechter C, Burton W, Mulvihill M. Predictors of follow-up of atypical and ASCUS Pap test results in a high-risk population. J Fam Pract 2001;50:609.
29. Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med 1999;8:510.
30. Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: A preventive telephone counseling strategy. J Natl Cancer Inst 1997;89:703.
31. Nelson K, Geiger AM, Mangione CM. Effect of health beliefs on delays in care for abnormal cervical cytology in a multiethnic population. J Gen Intern Med 2002;17:709.
32. Paskett ED, Phillips KC, Miller ME. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995;86:353.
33. Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: A randomized controlled trial. Prev Med 1990;19:630.
34. Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc 2003;95:825.
35. Takacs P, Chakhtoura N, DeSantis T. Video colposcopy improves adherence to follow-up compared to regular colposcopy: A randomized trial. Arch Gynecol Obstet 2004;270:182.
36. Trimble EL, Harlan LC, Clegg LX. Untreated cervical cancer in the United States. Gynecol Oncol 2005;96:271.
37. Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med 1995;24:610.
38. Fylan F. Screening for cervical cancer: A review of women's attitudes, knowledge, and behavior. Br J Gen Pract 1998;48:1509.
39. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of cytologic cervical screening. Am J Obstet Gynecol 1991;165:658.
40. Breitkopf CR, Catero J, Jaccard J, Berenson AB. Psychological and sociocultural perspectives on follow-up of abnormal Papanicolaou results. Obstet Gynecol 2004;104:1347.
41. Coker AL, Bond SM, Brandt HM. Reasons women discontinue paid follow-up care for pre-invasive neoplasia. Am J Epidemiol 2002;155(11)Suppl:S3.
42. Lovejoy NC, Roche N, McLean D. Life stress and risk of precancerous cervical lesions: A pretest directed by the life stress model. Oncol Nurs Forum 1997;24:63.
43. Lauver DR, Baggot A, Kruse K. Women's experiences in coping with abnormal Papanicoloau results and follow-up colposcopy. J Obstet Gynecol Neonat Nurs 1999;28:283.
44. Wagner TH, Engelstad LP, McPhee SJ, Pasick RJ. The cost-effectiveness of an outreach intervention for women with abnormal pap smears: VA Palo Alto and Stanford University, 2005.